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ABSTRACT
OBJECTIVE: To estimate life expectancy with and without depressive symptoms in older adults 
for the years 2000 and 2010. 
METHODS: We evaluated individuals aged 60 years or older (n = 1,862 in 2000 and n = 1,280 in 
2010), participants of the Saúde, Bem-Estar e Envelhecimento (SABE – Health, Wellbeing and Aging) 
study in in Sao Paulo, Southeastern Brazil. Depression was measured using the shorter version of the 
Geriatric Depression Scale (GDS-15); respondents scoring ≥ 6 were classified as having depression. 
Estimates of life expectancy with and without depression were obtained using the Sullivan method. 
RESULTS: Data from 2000 indicate that 60-year-old men could expect to live, on average, 
14.7 years without depression and 60-year-old women could expect to live 16.5 years without 
depression. By 2010, life expectancy without depression had increased to 16.7 years for men 
and 17.8 years for women. Expected length of life with depression differed by sex, with women 
expected to live more years with depression than men. 
CONCLUSIONS: Between 2000 and 2010, life expectancy without depression in Sao Paulo 
increased. However, older adults in Brazil, especially older women, still face a serious burden 
of mental illness. 
DESCRIPTORS: Aged. Life Expectancy. Aging. Depression, epidemiology. Gender and Health. 
Health Surveys.
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INTRODUCTION
Depression is a common mental health condition among older adults in Brazil. Researchers 
have estimated that more than 25.0% of community-dwelling older adults in Brazil have 
clinically significant depressive symptoms and 7.0% have major depression4. These rates are 
even higher among older adults who are hospitalized or living in long-term facilities. A recent 
meta-analysis found that the prevalence of clinically significant depressive symptoms varied 
from 20.0%-56.0% among hospitalized older adults in Brazil, and the rates among older 
adults in long-term care facilities varied from 11.0%-65.0%11. Chisholm et al.12 estimated that 
it would cost US$170 per capita per year to cover the direct expenses of treating individuals 
with subclinical depression in the Country. 
Experiencing depression at an older age has important implications for individuals, 
families and society. Among older adults, depression causes individual and family 
suffering and is associated with poor adherence to recommended medical treatment15, 
poor lifestyle behaviors34, cognitive impairment24, and physical disability9,27. In turn, these 
factors are associated with lower quality of life7,16, higher level of health care use7,8, and 
higher mortality rates28. 
Many factors can trigger the onset of depressive symptoms among older adults. Medical 
disorders such as cancer, metabolic disorder, heart disease, and stroke are commonly 
associated with depressive symptoms28. Limitations in daily activities, cognition, and mobility 
as well as social changes (such as retirement, bereavement, social isolation, and relocation) 
also influence mood and distress, leading to depressive symptoms. Because the prevalence 
of these conditions increases with age, researchers and policy makers should not overlook 
depressive symptoms among the older population. 
Life expectancy among older adults in Brazil has increased in recent decades. Life expectancy 
at birth increased from 51 to 72 years from 1950-2010, and is expected to reach 77.4 years 
by 2030a. During the same period, the proportion of older adults grew from 5.0% of the total 
population to about 10.0%. By 2030, the older adult population is expected to more than 
double, reaching 40.7 million people or 17.1% of the total Brazilian populationb. 
While previous studies have provided important estimates of the prevalence of clinically 
significant depressive symptoms and major depressive symptoms among older adults 
in Brazil, as well as the factors associated with those conditions, to the best of our 
knowledge, no studies have estimated the length of life with depressive symptoms, 
information that would help researchers and policy makers better understand the 
burden of this condition for this fast-aging society. Given that life expectancy among 
older adults in Brazil has increased in recent decades, estimates of life expectancy with 
and without depression are critical to the accurate determination of current and future 
social and medical service needs. 
In this study, we estimated life expectancy with and without depressive symptoms among 
older adults for the years 2000 and 2010. 
METHODS
This study analyzed data from the Saúde, Bem-Estar e Envelhecimento (SABE – Health, Wellbeing 
and Aging) survey, a longitudinal study of a probabilistic sample of older adults (age 60 and 
older) of both sexes living in the city of Sao Paulo, SP, Southeastern Brazil. The first wave of 
the SABE survey was conducted in 2000 with a sample of 2,143 respondents obtained using 
a two-stage stratified sampling method. Individuals aged 75 or older were oversampled to 
compensate for the group’s higher mortality rate and smaller probability of being sampled. 
Details of the study sampling methodology can be found elsewhere22. In 2006, a second wave 
of data was collected (n = 1,413). The sample for the follow-up data collection included the 
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1,115 older adults from the baseline study and 298 new respondents age 60-64. Data collection 
procedures were the same as in the baseline study. In 2010, a third wave of data was collected 
(n = 1,345). Three groups participated in that wave: a) 748 respondents from the baseline study, 
b) 242 respondents from the 2006 study, and c) 355 new respondents age-64.
The study reported here focuses on the cross-sectional prevalence rates of depression 
estimated from data obtained in 2000 and 2010. Sample weights for 2000 were calculated 
based on the 2000 census and weights for the 2010 sample were based on the 2010 census.
Depression was measured using the shorter version of the Geriatric Depression Scale (GDS-15) 
in the SABE survey. The GDS-15 short form was based on the GDS-3037 and has been widely 
used in clinical and population-based studies as a screening instrument for late-life depression. 
Several studies have analyzed the scale’s validity and reliability, and have found that the 
instrument has good specificity and sensitivity30. SABE used a GDS-15 questionnaire validated 
for use in Brazil1. Individuals with missing data on more than five items were excluded from the 
analysis. We used prorated procedures to estimate scores for respondents with missing data 
on five or fewer items. The Cronbach’s alpha coefficient for the total scale was 0.82 for both 
years. We used a GDS-15 cutoff score of ≥ 6 points to classify individuals as having depression1. 
Mortality data were obtained from the Fundação Sistema Estadual de Análise de Dados 
(SEADE Foundation – State System for Data Analysis Foundation)c, which provides data on 
social, demographic, and economic status for the State of Sao Paulo. We generated estimates 
for 2000 and 2010 using the 1999-2000-2001 and 2009-2010-2011 tables. 
Sex was included as a covariate when disaggregating the data, given sex differences in 
mortality and prevalence of depressive symptoms. We estimated prevalence rates and 95% 
confidence intervals using sampling weights with Stata-SE version 12.1. Logistic regressions 
were used to assess sex and wave-related differences. 
The Sullivan method (Sullivan, 1997) was used to estimate life expectancy with and without 
depression. The method employs a standard life table with two states, alive and dead. The alive 
state is subdivided into two categories, healthy (nondepressed) and unhealthy (depressed), 
using data on the observed prevalence of depression6,22,d. The major inputs are the age-specific 
prevalence of depressed and nondepressed states in the population and age-specific mortality 
rates. The expected years in the nondepressed state and expected years in the depressed 
state were estimated by applying the age- and sex-specific cross-sectional prevalence rates 
for nondepressed and depressed respondents, respectively, to the person-years lived in 
different age groups (derived from the period life tables). 




Life Expectancy with Depressionx 
Life Expectancy with Depressionx
xl
Σ(npix) nLx
Healthy life expectancy (HLE) is the average number of years an individual is expected to live 
without depression, starting at an exact age x; life expectancy with depression represents the 
average number of years an individual is expected to live with depression, starting at an exact age 
x. To calculate HLE and life expectancy with depression, we used the prevalence of depression 
for individuals aged x to x + n (nπx) (obtained from the SABE survey), the total number of years 
of life expectancy for individuals aged x to x + n (nLx), and the survival probability for exact age x 
(lx). The last two variables were obtained from the life table generated from estimates provided 
by SEADE. Total life expectancy (TLE) is the sum of healthy (HLE) and unhealthy years of life. 
These estimates are independent of the age structure of the population. 
The SABE survey was approved by the Research Ethics Committee of the Faculdade de 
Saúde Pública, Universidade de São Paulo, Brazil (Process: 67/99) and by the Brazilian 
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National Ethics Committee (Process 315/99). Participation in the study was voluntary, and 
each respondent signed an informed consent form. The present study was approved by the 
Institutional Review Board at the University of Illinois.
RESULTS
In 2000 and 2010, respectively, 281 (13.1%) and 65 subjects (4.8%) had missing data on 
depressive symptoms. In both years, those with missing data were older than those with 
complete data (in 2000, 80.8 years versus 72.1, p < 0.001; in 2010, 83.5 years versus 72.3, 
p < 0.001); however, there were no sex differences between the two groups. 
Table 1 shows the results related to the prevalence of depression in 2000 and 2010 (weighted 
estimates) in the Sao Paulo population of older adults. Among the 1,862 participants in the 2000 
sample, 21.8% (95%CI 19.7–24.0) were categorized as having depression (i.e., scored 6 or more on 
the GDS scale). The prevalence rate did not change over time: 21.1% (95%CI 18.8–23.6) of the 1,280 
older adults in the 2010 sample were categorized as having depression. In the logistic regression 
models (results not shown, but available upon request), depression was more common among 
women than among men in both periods, even after controlling for age (p < 0.0001). The depression 
rate for men was 16.3% in 2000 and 14.4% in 2010, whereas the rate for women was about one 
fourth of the population in each year (25.7% in 2000 and 25.2% in 2010). 
TLE increased in Sao Paulo from 2000 to 2010 for both men and women (Table 2). TLE at age 
60 increased from 17.5 years to 19.4 years for men and from 22.0 years to 23.7 years for women. 
The estimated average number of years lived without depression also increased. Among men, 
HLE at age 60 was 14.7 years in 2000 and 16.7 years in 2010, an increase of two years. Among 
women, the gain was smaller: HLE at age 60 was 16.5 years in 2000 and 17.8 years in 2010. 
Table 1. Prevalence and 95%CI of depression among older adults in Sao Paulo, Brazil: 2000 and 2010 
(weighted estimates).
Sex and age groups
2000 2010
% 95%CI % 95%CI
All participants 21.8 19.7–24.0 21.1 18.8–23.6
60-64 21.4 17.7–25.7 23.3 18.9–28.3
65-69 24.5 20.3–29.2 15.1 10.8–20.6
70-74 21.3 17.0–26.4 20.6 15.5–26.9
75-79 18.7 15.0–23.1 23.7 17.3–31.5
80-84 16.9 12.4–22.7 22.8 16.3–30.8
≥ 85 23.0 15.1–33.4 22.0 16.0–29.5
Males 16.3 13.4–19.6 14.4 11.2–18.2
60-64 14.6 10.0–21.0 15.3 9.8–23.2
65-69 17.7 12.1–25.2 8.5 3.7–18.1
70-74 19.5 13.1–27.9 11.0 5.3–21.5
75-79 14.4 9.9–20.7 17.4 8.8–31.4
80-84 13.1 7.9–20.9 14.8 6.7–29.5
≥ 85 11.9 5.6–23.5 21.5 13.0–33.3
Females 25.7 22.9–28.7 25.2 22.1–28.5
60-64 26.8 21.5–32.8 28.6 22.7–35.4
65-69 29.5 23.9–35.9 19.0 13.2–26.4
70-74 22.5 17.1–29.2 25.9 19.1–34.2
75-79 21.4 16.3–27.5 27.1 19.0–37.1
80-84 18.9 12.8–26.9 26.3 18.2–36.4
≥ 85 29.7 18.3–44.5 22.5 14.8–32.8
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In both 2000 and 2010, the ratio of healthy years to total years was higher for men than for 
women. This result suggests that although women lived longer than men, on average, women 
were more likely to spend a higher percentage of their remaining lives with depression than 
men. Both men and women experienced very little change in life expectancy with depression 
over time. On average, women at age 60 were expected to live 5.5 years with depression in 
2000 and 5.9 years in 2010. For men at age 60, life expectancy with depression was 2.8 years 
in 2000 and 2.7 years in 2010. 
DISCUSSION
Findings show that from 2000-2010, both TLE and life expectancy without depression 
increased among older adults in Sao Paulo, which may reflect living more years with higher 
quality of life, less disability, and better health status28. Given the association between 
depression and mortality, the recent gains in life expectancy without depression can increase 
TLE by reducing the number of premature deaths due to several causes (e.g., suicide). 
Life expectancy and HLE are related to economic and social capital as well as social 
inequalities. In Brazil, the 2000-2010 period was marked by economic growth, improvements 
in social indicators, and reductions in social inequalities. According to the World Bank’s World 
Development Indicators database, per capita gross domestic product (measured in US dollars 
at 2005 prices) grew from US$4,407 in 2000 to US$5,618 in 201026. The human development 
index, a composite measure including health, schooling, and income, has also improved in 
Brazil over recent decadese. The Gini coefficient, a measure of income inequality ranging 
from 0 (complete equality) to 1 (complete inequality), fell from 0.59 in 2000 to 0.54 in 2009. 






















60 20.0 15.7 14.7–16.6 78.7 4.3 21.6 17.1 15.7–18.2 79.0 4.5
65 16.5 13.0 12.1–13.8 78.7 3.5 17.9 14.3 13.1–15.3 79.7 3.6
70 13.4 10.7 9.9–11.4 79.9 2.7 14.5 11.3 10.3–12.2 77.8 3.2
75 10.5 8.5 7.8–9.0 80.6 2.0 11.4 8.8 7.9–9.5 77.1 2.6
80 8.1 6.5 5.8–7.0 80.1 1.6 8.7 6.8 6.1–7.3 77.6 2.0
85 6.1 4.7 4.1–5.2 77.0 1.4 6.4 5.0 4.5–5.4 78.0 1.4
Males
60 17.5 14.7 13.4–15.6 84.0 2.8 19.4 16.7 14.6–17.9 86.1 2.7
65 14.3 12.0 10.8–12.8 83.7 2.3 16.0 13.8 12.0–14.9 86.5 2.2
70 11.5 9.7 8.8–10.4 84.6 1.8 12.8 10.9 9.3–11.8 85.0 1.9
75 9.1 7.9 7.1–8.3 86.5 1.2 10.1 8.3 6.9–9.1 82.0 1.8
80 7.0 6.1 5.4–6.5 87.3 0.9 7.7 6.3 5.3–7.0 82.4 1.4
85 5.4 4.8 4.1–5.1 88.3 0.6 5.7 4.5 3.8–5.0 78.9 1.2
Females
60 22.0 16.5 14.8–17.9 75.0 5.5 23.7 17.8 15.7–19.4 75.0 5.9
65 18.2 13.7 12.3–14.9 75.5 4.5 19.6 14.9 13.2–16.3 76.2 4.7
70 14.7 11.3 10.1–12.3 77.0 3.4 15.9 11.8 10.3–13.1 74.5 4.1
75 11.5 8.8 7.7–9.6 76.6 2.7 12.4 9.3 8.0–10.3 75.0 3.1
80 8.7 6.5 5.6–7.3 75.3 2.2 9.4 7.1 6.2–7.9 75.8 2.3
85 6.5 4.5 3.6–5.3 70.0 2.0 6.8 5.3 4.6–5.8 77.5 1.5
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These values indicate a favorable change in several social and economic factors, which may 
have increased both TLE and life expectancy without depression.
The results support previous findings showing a higher prevalence of depression and 
depressive symptoms among older women than among older men in developing countries, 
including Brazil3,4,20,32. A larger proportion of older women than older men in Sao Paulo have 
depression and women can expect to live a higher proportion of their remaining lives with 
depression than men. These findings are consistent with previous research on life expectancy 
and HLE, which has found that even though women live longer lives, they live more years 
with health problems such as disability, cognitive impairment, and mental health problems2. 
This study has some limitations. First, the measure of depression prevalence differed from 
the measure used in other studies. In this study, participants’ depressive symptoms were 
reported using the GDS 15-item subscale, and we used a cutoff score of 6. Other studies on 
the prevalence of depressive symptoms among Brazilians have used other measures, different 
cutoff points, or alternative ways of dealing with item nonresponse, all of which influence the 
estimated prevalence rate. For example, our estimate was higher than a previous estimate of 
the depression rate for older adults in Sao Paulo from 2002-2004 (22.0% versus 13.0%)3; which 
measured depression based on questions from the GDS-30 and the Center for Epidemiologic 
Studies Depression Scale (CES-D 10)17,33. The current results also differ from the original SABE 
reports19, which used different procedures for handling item nonresponse. Finally, our results 
were lower than the ones of a meta-analysis that reported a 26.0% prevalence of clinically 
significant depressive symptoms among older community-dwelling adults in Brazil4. 
A second limitation of the study is related to the data collection procedures for depressive 
symptoms; these symptoms were self-reported by those who were cognitively intact, but those 
with cognitive limitations (n = 198 in 2000 and n = 196 in 2010) failed to provide information 
on depressive symptoms. Although missing data could also be considered an important 
limitation, when we compared the characteristics of respondents with missing data and those 
with no missing data (at baseline), only age differed significantly. In further analyses (results 
not shown, but available upon request), we imputed data for those with missing information 
on more than five items. Imputed prevalence rates differed slightly from the rates used in the 
study (21.2% versus 21.8% in 2000, respectively, and 21.7% versus 21.1% in 2010, respectively). 
When imputed values were calculated separately by sex, differences remained small, with all 
imputed prevalence rates decreasing slightly, except the rate for women in 2010 (imputed rate 
was 25.9%, compared with the 25.2% rate used in the analyses). Even when separated by sex, 
all imputed values were within the confidence intervals presented in Table 2. 
A third limitation of the study is that estimates of depression may be biased because we did not 
include respondents living in nursing homes at baseline and depression may be higher among this 
segment of the population. However, this population in Brazil is small – about 1.0% according to 
Camarano and Kanso10 and 0.5% according to the SABE survey; therefore, this bias is likely trivial.
Other limitations originate from the application of the Sullivan method. We employed 
the Sullivan method because the goal of the article was to evaluate trends over time in 
life expectancy with and without depression. However, we used a stationary population 
approach to interpret the estimates produced via Sullivan method, and thus results should 
be interpreted with caution because the data are dependent on past conditions of the 
population22. Another potential issue related to using mortality rates from life tables is that 
we did not formally account for the association between depression and increased mortality 
risk25. An alternative to the current analytical strategy would be to incorporate mortality 
by health state and health transitions (i.e., incidence and recovery) using multistate life 
tables21. However, as shown in other settings, longitudinal surveys tend to underestimate 
deaths as a result of the omission of respondents living in nursing homes in the baseline data 
as well as the potential of missing deaths in follow-up waves18,29. Finally, due to the lack of 
nationally representative data on the depression prevalence in Brazil, the results from this 
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study reflect only the experiences of older adults in Brazil’s largest city, which may differ 
from the experiences of older people throughout the Country.
Life expectancy without depression increased from 2000 to 2010 in Sao Paulo. Further 
improvements in quality of life can be obtained by early diagnosis and treatment of individuals 
with depression. However, the underdiagnosis of depression is a serious health problem, 
particularly in countries such as Brazil in which many residents lack adequate access to 
healthcare services for diagnosis and treatment. In order to expand services and healthcare, 
the number of mental health care workers must increase, and access to care must improve.
Given the limited resources available, community and primary health workers can be trained 
to perform some roles under the supervision of specialists. Some authors have called for “task 
shifting” programs in which nonspecialists can complete certain tasks, such as identifying 
cases, providing referrals, supporting medication adherence, and delivering psychosocial 
treatment13,15. Given the associations between mental health conditions and other health 
conditions, integrating mental health care into general health care is another change that has 
the potential to improve outcomes13. In Brazil, the current Política Nacional de Saúde do Idoso 
(PNSI – National Policy for the Health of the Elderly) seeks to improve older adults’ health 
and well-being through improved immunization and distribution of medication23. A more 
diverse and larger workforce is also needed to deliver interventions aimed at modifying 
behaviors – such as physical exercise – that can improve the health outcomes of individuals 
with depressive symptoms5.
Finally, other innovations may involve using technology to improve medical care by expanding 
training and improving access to care and treatment in Brazil. Ultimately, empowering 
Brazilian individuals with depression and their families can lead to additional advocacy for 
better services, improved social inclusion, and reduced stigma13. All of these changes have the 
potential to facilitate early diagnosis, better treatment, and increased healthy life expectancy. 
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